Scarica l'app Stockscreener
5.43
2.34%
-0.13
Dopo l'orario di chiusura:
5.42
-0.010
-0.18%
Cytomx Therapeutics Inc Borsa (CTMX) Ultime notizie
CytomX Therapeutics Conference: CFO Highlights Varseta-M CRC Response Data, Next Catalysts - MarketBeat
FMR LLC's Strategic Acquisition of CytomX Therapeutics Inc Shares - GuruFocus
CytomX at Guggenheim Summit: Promising CRC Treatment Path By Investing.com - Investing.com Canada
Stock Recap: Is CytomX Therapeutics Inc benefiting from interest rate changes2025 Institutional Moves & Capital Protection Trade Alerts - baoquankhu1.vn
How New Analyst Assumptions Are Rewriting The Story For CytomX Therapeutics (CTMX) - Yahoo Finance
Rally Mode: Can CytomX Therapeutics Inc navigate macro headwindsJuly 2025 PreEarnings & High Yield Equity Trading Tips - baoquankhu1.vn
Analysts bullish ahead of colorectal cancer readout for CytomX Therapeutics, Inc. (CTMX) - MSN
CytomX Therapeutics, Inc. (CTMX) Investor Outlook: Exploring a 58.73% Potential Upside Amid Innovative Oncology Developments - DirectorsTalk Interviews
Analysis Recap: Whats the profit margin of CytomX Therapeutics IncWeekly Trend Summary & Smart Investment Allocation Tips - baoquankhu1.vn
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
CytomX Therapeutics (CTMX) Price Target Increased by 20.20% to 8.67 - Nasdaq
Cantor Fitzgerald Raises Price Target for CytomX Therapeutics (C - GuruFocus
Cantor Fitzgerald Raises CytomX Therapeutics (NASDAQ:CTMX) Price Target to $10.00 - MarketBeat
CTMX: Barclays Analyst Raises Price Target to $10.00 | CTMX Stock News - GuruFocus
CytomX Therapeutics to Present at Upcoming February Conferences - 富途牛牛
CytomX Therapeutics price target raised to $10 from $8 at Barclays - TipRanks
A Look At CytomX Therapeutics (CTMX) Valuation After Optimistic Analyst Target Hikes On Phase 1 Cancer Data - Sahm
CytomX Therapeutics stock hits 52-week high at 6.16 USD By Investing.com - Investing.com Nigeria
CytomX Therapeutics (NASDAQ:CTMX) Hits New 1-Year HighHere's Why - MarketBeat
CytomX Therapeutics stock hits 52-week high at 6.16 USD - Investing.com
CytomX Therapeutics (CTMX) Is Up 14.0% After Early Probody Colorectal Cancer Data Are Welcomed By Analysts – Has The Bull Case Changed? - Yahoo Finance
Analysts Bullish Ahead of Colorectal Cancer Readout for CytomX Therapeutics, Inc. (CTMX) - Insider Monkey
Can CytomX Therapeutics Inc. disrupt its industryProfit Target & Consistent Growth Equity Picks - mfd.ru
CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Biotech Innovator with 44% Potential Upside - DirectorsTalk Interviews
Will CytomX Therapeutics Inc. benefit from AI trendsRate Hike & Daily Volume Surge Signals - mfd.ru
What CytomX Therapeutics, Inc.'s (NASDAQ:CTMX) 35% Share Price Gain Is Not Telling You - simplywall.st
CytomX stock rises 31% in a month: Here's what you should know - MSN
Fed Watch: What is CytomX Therapeutics Incs TAM Total Addressable MarketMarket Sentiment Summary & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Is CytomX Therapeutics, Inc.'s (NASDAQ:CTMX) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? - simplywall.st
Forecast Cut: Does RAPT Therapeutics Inc stock benefit from AI growthJuly 2025 Closing Moves & Low Risk High Reward Trade Ideas - baoquankhu1.vn
CytomX Therapeutics (NASDAQ:CTMX) Sets New 1-Year HighShould You Buy? - MarketBeat
Patterns Watch: Is CytomX Therapeutics Inc benefiting from interest rate changesJuly 2025 Momentum & AI Driven Stock Price Forecasts - baoquankhu1.vn
CytomX Therapeutics (NASDAQ:CTMX) Shares Down 5.3%Here's Why - MarketBeat
Guggenheim Upgrades CytomX Therapeutics (NASDAQ:CTMX) to "Strong-Buy" - MarketBeat
Piper Sandler raises CytomX Therapeutics stock price target to $10 on cancer drug data - Investing.com Canada
CTMX: Barclays Raises Price Target from $6.00 to $8.00, Maintains Overweight Rating | CTMX Stock News - GuruFocus
Guggenheim Initiates Coverage of CytomX Therapeutics (CTMX) with Buy Recommendation - Nasdaq
Guggenheim Initiates Coverage on CytomX Therapeutics (CTMX) with 'Buy' Rating | CTMX Stock News - GuruFocus
CytomX Therapeutics (CTMX) Receives Target Price Upgrade from Pi - GuruFocus
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Formidable Asset Management LLC Sells 194,513 Shares of CytomX Therapeutics, Inc. $CTMX - MarketBeat
CytomX Stock Rises 31% in a Month: Here's What You Should Know - Yahoo Finance
Risk Analysis: What is LILAKs book value per shareGDP Growth & AI Powered Trade Plan Recommendations - baoquankhu1.vn
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected - 富途资讯
CytomX Therapeutics (NASDAQ:CTMX) Reaches New 12-Month HighHere's What Happened - MarketBeat
CytomX Therapeutics' (NASDAQ:CTMX) investors will be pleased with their incredible 402% return over the last year - Yahoo Finance
CTMX Stock Price, Forecast & Analysis | CYTOMX THERAPEUTICS INC (NASDAQ:CTMX) - Chartmill
Volatility Watch: Does CytomX Therapeutics Inc have strong EBITDA margins2025 Trading Volume Trends & Weekly Watchlist of Top Performers - baoquankhu1.vn
CTMX: Vaseta M and CX801 advance in clinical trials, targeting major unmet needs in oncology - TradingView
Is CytomX Therapeutics Inc stock heavily shortedEarnings Overview Summary & Verified Short-Term Plans - baoquankhu1.vn
Drugmaker signed East Bay's biggest Q4 lease, moving away from South San Francisco - The Business Journals
Bull Run: Is CytomX Therapeutics Inc. stock a top pick in earnings seasonJobs Report & Reliable Price Breakout Alerts - Bộ Nội Vụ
Guidance Update: What hedge funds are buying CytomX Therapeutics Inc2025 AllTime Highs & Verified Technical Trade Signals - baoquankhu1.vn
Swing Trade: Will CytomX Therapeutics Inc stock recover faster than market2025 Buyback Activity & Real-Time Buy Zone Alerts - Bộ Nội Vụ
Breakout Zone: Is CytomX Therapeutics Inc. stock gaining market shareJuly 2025 Action & Weekly Setup with ROI Potential - Улправда
Gainers Report: Will CytomX Therapeutics Inc stock recover faster than marketWeekly Volume Report & Free Technical Pattern Based Buy Signals - Bộ Nội Vụ
1.24%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):